Manufacture and evaluation of a HER2-positive breast cancer immunotoxin 4D5Fv-PE25

Human epidermal growth factor receptor 2 (HER2) positive breast cancer is an aggressive subtype, accounting for around 20% of all breast cancers. The development of HER2-targeted therapy has substantially impr...

Source: Microbial Cell Factories - May 17, 2023 Category: Microbiology Authors: Yanjie Peng, Zhengli Wu, Zheng Pang, Lin Zhang, Dandan Song, Fang Liu, Yanhong Li and Tongjun Lin Tags: Research Source Type: research